Two Climate Change Bills, COVID Vaccine Boosters. Sept 24, 2021, Part 1
Ice-Hunting Lunar Rover Robot Gets A Landing Site
This week, NASA announced that it had selected a destination for a planned robotic lunar rover called VIPER, the Volatiles Investigating Polar Exploration Rover. The mission is planned for launch in 2023, and will rove about the Moon’s south pole, mapping the location and concentration of water ice deposits. The plan is for a commercial spaceflight mission to deliver the rover to a spot near the western edge of the Nobile Crater at the Moon’s south pole.
Sophie Bushwick, technology editor at Scientific American, joins Ira to talk about the mission and other stories from the week in technology and science—including tiny airborne micro-machines, an upcoming voyage for the James Webb Space Telescope, and the discovery of ancient kids’ handprints that could be the world’s oldest-known art.
Congress Is Considering Two Climate Change Bills. What’s In Them?
President Biden has made many promises about slowing climate change. During his campaign, he pledged to bring the United States’ energy sector to zero carbon emissions by 2035. On Earth Day this year, he pledged to reduce total U.S. greenhouse gas emissions by 50% by 2030, and by 100% by 2050.
But the key policy changes that will help the country get there remain pending as the relevant bills continue to make their way through Congress. The first is an infrastructure bill that would pledge billions toward cleaner transit and resiliency projects in disaster-stricken communities. But that measure is tied intricately with the fate of a second, $3.5 trillion budget bill that would direct billions of dollars to incentivize coal and natural gas-burning utilities to switch over to renewable energy.
If both are to pass without substantial changes, they rely on consensus among the narrow majorities of Democrats in the Senate and the House—neither of which is guaranteed.
New York Times reporter Coral Davenport walks through what’s in the bills, and why so much is still up in the air even after a summer of climate-driven disasters.
Behind The Booster Battle
Update 9/24/2021: This week, CDC director Rochelle Walensky overruled the recommendations of an advisory panel and authorized a third dose of the Pfizer COVID-19 vaccine for the elderly and certain “high risk” individuals, mirroring an earlier FDA decision. In late August, President Biden had said that COVID-19 vaccine booster shots might soon be on the horizon for many Americans.
In late August, President Biden said that COVID-19 vaccine booster shots might soon be on the horizon for many Americans. But last Friday, an FDA advisory committee voted to recommend booster doses only for people over age 65—and this Wednesday, the FDA authorized Pfizer boosters for use in the elderly and “high risk” individuals.
In the republished article (which you can read on sciencefriday.com) from September 16, written before the FDA review, Kaiser Health News’ Arthur Allen and Sarah Jane Tribble examine the backstory behind the debate over boosters, and how leaders from the NIH got out in front of FDA and CDC recommendations.
Subscribe to this podcast. Follow our show on Instagram, TikTok, Facebook, and Bluesky @scifri and sign up for our newsletters. Got a science question that’s keeping you up at night? Call us: 877-472-4374
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Available Results
Generated results are saved to your library for reuse and search.
Choose Template
Pick the result you want. You can review provider and model before generating.
A concise first-pass summary for understanding the episode quickly.
A comprehensive, source-grounded extraction of the reusable knowledge in an episode.
A comprehensive extraction focused on health practices, protocols, claims, and safety caveats.
A dedicated analysis of warnings, limitations, trade-offs, weak evidence, and uncertainty.
Repeatable methods, frameworks, mental models, processes, and systems.
A comprehensive extraction focused on opportunities, strategy, markets, and company building.
A concise first-pass summary for understanding the episode quickly.
A detailed readable summary organized by chapter or topic.
A navigable map of subjects, topic flow, and suggested chapters.
A comprehensive, source-grounded extraction of the reusable knowledge in an episode.
Reusable atomic knowledge units extracted from the episode.
A comprehensive extraction focused on health practices, protocols, claims, and safety caveats.
A comprehensive extraction focused on opportunities, strategy, markets, and company building.
Explicit actions, next steps, habits, recommendations, and things to avoid.
A dedicated inventory of concrete resources named in the episode.
A dedicated analysis of warnings, limitations, trade-offs, weak evidence, and uncertainty.
A concise first-pass summary for understanding the episode quickly.
A detailed readable summary organized by chapter or topic.
A navigable map of subjects, topic flow, and suggested chapters.
A comprehensive, source-grounded extraction of the reusable knowledge in an episode.
Reusable atomic knowledge units extracted from the episode.
A comprehensive extraction focused on health practices, protocols, claims, and safety caveats.
A comprehensive extraction focused on opportunities, strategy, markets, and company building.
Scientific findings, mechanisms, studies, hypotheses, and the limits of the evidence discussed.
Technologies, AI models, technical methods, capabilities, limitations, and adoption implications.
Investment theses, assets, catalysts, valuation reasoning, time horizons, and risks.
Chronologies, actors, causes, consequences, turning points, and competing historical interpretations.
Policies, proposals, stakeholders, arguments, implementation constraints, and predicted effects.
Career paths, skills, hiring signals, workplace decisions, transitions, and limitations of the advice.
Behavioral mechanisms, biases, motivation, habits, emotions, interventions, and evidence limitations.
Economic mechanisms, incentives, indicators, market structure, forecasts, and uncertainty.
Leadership principles, team systems, organizational design, culture, feedback, and failure modes.
Audience, positioning, messaging, acquisition, retention, experiments, metrics, and failed approaches.
Teaching methods, learning strategies, practice, feedback, assessment, and effectiveness evidence.
Theses, premises, arguments, objections, values, thought experiments, and unresolved questions.
Communication patterns, conflict, boundaries, expectations, repair methods, and contextual limitations.
Books, papers, authors, courses, and other learning resources mentioned in the episode.
Repeatable methods, frameworks, mental models, processes, and systems.
Explicit actions, next steps, habits, recommendations, and things to avoid.
Memorable statements and important claims with attribution and source context.
A dedicated inventory of concrete resources named in the episode.
A dedicated analysis of warnings, limitations, trade-offs, weak evidence, and uncertainty.